Attitudes Toward Long-Term Medication Use—A Comparison Between Concerned Populations and a Sample From the German General Population
- 14 June 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 39 (4) , 357-361
Abstract
The present study was conducted to investigate the difference in attitudes toward psychiatric drugs, long-term medication, and depot formulations between psychiatric patients and patient-related groups and the German general public. Different groups (n = 50 patients, n = 34 relatives of patients, n = 42 psychiatrists, n = 70 medical students, and n = 58 psychiatric nursing professionals) were surveyed using a questionnaire to investigate their attitude toward depot medication and compared with matched participants from the German general public. Patients did not differ from their matched controls regarding their attitude toward potential reasons to reject a depot, whereas psychiatrists (P = 0.002) and nursing staff (P = 0.003) were more concerned about patients fearing an injection than their matched controls. Psychiatrists and psychiatric nurses were significantly more concerned about giving an (intragluteal) injection because of concerns about patients' fears of this administration method than their matched controls. In contrast, patients' concerns about receiving an injection did not differ from their matched controls. Furthermore, we found that psychiatrists tended to believe that giving an injection might be time-consuming than giving oral medication. These results may emphasize the fact that the low rate of depot medication use is derived from subjective reservations of medical staff rather than actual negative attitudes or fears of patients.Keywords
This publication has 17 references indexed in Scilit:
- Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illnessBMC Psychiatry, 2013
- Efficacy and Effectiveness of Depot Versus Oral Antipsychotics in SchizophreniaThe Journal of Clinical Psychiatry, 2013
- Oral versus depot antipsychotic drugs for schizophrenia—A critical systematic review and meta-analysis of randomised long-term trialsSchizophrenia Research, 2011
- Long-Acting Risperidone and Oral Antipsychotics in Unstable SchizophreniaNew England Journal of Medicine, 2011
- The cost of relapse and the predictors of relapse in the treatment of schizophreniaBMC Psychiatry, 2010
- Attitudes towards long-acting depot antipsychotics: A survey of patients, relatives and psychiatristsPsychiatry Research, 2010
- Attitudes of patients and mental health staff to antipsychotic long-acting injections: Systematic reviewThe British Journal of Psychiatry, 2009
- A Cross-Sectional Study of Patients' Perspectives on Adherence to Antipsychotic MedicationThe Journal of Clinical Psychiatry, 2008
- Equivalent Switching Dose From Oral Risperidone to Risperidone Long-Acting InjectionThe Journal of Clinical Psychiatry, 2007
- Attitudes of Psychiatrists Toward Antipsychotic Depot MedicationThe Journal of Clinical Psychiatry, 2006